FIELD: medicine.
SUBSTANCE: group of inventions relates to treating cartilage tissue diseases, such as osteoarthritis or cartilage tissue injury. Two-component gelation system contains a first component containing FGF-18, alginate, collagen and sugar as a stabilizer, and a second component containing a dithionic salt. Also disclosed is a method of producing a two-component gelation system and an industrial product for double injection.
EFFECT: group of inventions provides gel formation in situ by combining two fluid components of the system in a patient's body by injecting two liquid solutions.
13 cl, 17 dwg, 3 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FGF-18 COMPOSITION IN XYLOGLUCAN GELS | 2014 |
|
RU2695343C2 |
| INJECTABLE COMPOSITION FOR PREVENTING HAIR LOSS OR STIMULATING HAIR GROWTH | 2017 |
|
RU2731421C1 |
| GEL COMPOSITION FOR RADIATION THERAPY UNDER VISUAL CONTROL | 2014 |
|
RU2703303C2 |
| SELF-GELATINISED ALGINATE SYSTEMS AND APPLICATION THEREOF | 2005 |
|
RU2393867C2 |
| POLYMER COMPOSITES OBTAINED BY SOL-GEL METHOD, AND THEIR APPLICATION | 2016 |
|
RU2761212C2 |
| IMPLANT CONTAINING FGF-18 | 2015 |
|
RU2700414C2 |
| PROCOAGULANT PEPTIDES, THEIR DERIVATIVES AND THEIR APPLICATION | 2012 |
|
RU2635510C2 |
| APPLICATION OF C-TYPE NATRIURETIC PEPTIDE VARIANTS FOR THE TREATMENT OF SKELETAL DYSPLASIA | 2016 |
|
RU2794515C2 |
| APPLICATION OF VARIANTS OF NATRIURETIC PEPTIDE OF C-TYPE FOR TREATMENT OF SKELETAL DYSPLASIA | 2016 |
|
RU2728567C2 |
| METHOD FOR PRODUCING CAPSULES BASED ON BACTERIAL CELLULOSE HYDROGELS | 2021 |
|
RU2775231C1 |
